Keywords: approval, merck, prostate, drug, received, usa, market

US APPROVAL FOR MERCK'S PROSTATE DRUG

Article | 29 June 1992

Merck has received approval in the USA to market its 5-alpha reductase inhibitor, Proscar (finasteride), for the treatment of benign ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in